What’s new in inflammatory bowel disease – a focus on biologic sequencing


Highlights from the 2023 European Crohn’s and Colitis Organisation (ECCO) Congress, covering inflammatory bowel disease, biologic therapies, new agents and strategies

Learning objectives

  • Therapies maximising the benefits of biologic therapies in Inflammatory Bowel Disease treatment
  • To understand Inflammatory Bowel Disease treatment targets and how they define efficacy
  • Therapy persistence and long-term treatment benefits Crohn’s Disease – evidence trials presented.

To access this module, please register or login: